ANTITHROMBOTIC THERAPY AND RISK BLEEDING IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION ON THE BACKGROUND TO COMORBID DISEASES

Authors

  • M. I. Shved I. Ya. Horbachevsky Ternopil State Medical University
  • O. L. Sydorenko I. Ya. Horbachevsky Ternopil State Medical University
  • N. M. Kovbasa I. Ya. Horbachevsky Ternopil State Medical University
  • M. YA. Beniv I. Ya. Horbachevsky Ternopil State Medical University
  • L. V. Tsuhlevych I. Ya. Horbachevsky Ternopil State Medical University

DOI:

https://doi.org/10.11603/2415-8798.2016.4.7134

Keywords:

atrial fibrillation, thromboembolic risk hemorrhagic complications, antithrombotic therapy.

Abstract

This article presents the stratification of risk for stroke, hemorrhagic complications and analysis of antithrombotic therapy in 116 patients with non-valvular atrial fibrillation. We reviewed informative and validity scales CHA2DS2-VASc and HAS-BLED in patients with atrial fibrillation on the background of comorbid disorders. The question of the adequacy of receiving anticoagulants and antiplatelet agents implied as a means of prevention of thromboembolic complications.

Author Biography

M. I. Shved, I. Ya. Horbachevsky Ternopil State Medical University

MD, PhD, DSc in Medicine, professor

References

Berko H. K. Taktyka antytrombotychnoyi terapiyi u patsiyentiv z neklapannoyu fibrylyatsiyeyu peredserdʹ / H. K. Berko, H. O. Movchan // Ukrayinsʹkyy kardiolohichnyy zhurnal. – 2014. – Dod. 4. – S. 127–128.

Zharinov O.Y. Antytrombotychna terapiya u patsiyentiv iz fibrylyatsiyeyu peredserdʹ u novykh yevropeysʹkykh rekomendatsiyakh / O. Y. Zharinov // Zdorovʺya Ukrayiny. – 2010. – № 22. – S. 23.

Rekomendatsiyi robochoyi hrupy po porushennyam sertsevoho rytmu Asotsiatsiyi kardiolohiv Ukrayiny, Diahnostyka ta likuvannya fibrylyatsiyi peredserdʹ, O. S. Sychov ta in. K., 2013. – S. 45.

Sychev O.S. Fybryllyatsyya predserdyy. Sovremennye podkhody k lechenyyu y profylaktyke oslozhnenyy u patsyentov s soput·stvuyushchey patolohyey serdtsa / O. S. Sychev // Ukrayinsʹkyy medychnyy chasopys. – 2011. – № 6 – S. 54.

Chastota rozvytku tromboembolichnykh uskladnenʹ u khvorykh z riznymy formamy fibrylyatsiyi peredserdʹ neklapannoho henezu ta zastosuvannya antytrombotychnykh preparativ (retrospektyvne doslidzhennya) / M. Z. Cherednichenko, O. S. Sychov, O. I. Frolov, L. O. Shabilʹyanova // Ukrayinsʹkyy kardiolohichnyy zhurnal. – 2008. – № 2. – S. 30–36.

Cherednychenko M. Z. Ryzyk rozvytku i profilaktyka tromboembolichnykh uskladnenʹ u khvorykh z fibrylyatsiyeyu peredserdʹ / M. Z. Cherednychenko // Ukrayinsʹkyy kardiolohichnyy zhurnal. – 2008. – № 1. – S. 110–120.

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation – executive summary // Eur. Heart J. – 2006. – Vol. 27. – P. 1979–2030.

A. John Guidelines for the management of atrial Fibrillation. The Task Forse for the Management of Atrial Fibrillation of the Europen Society of Cardiology ESC.Europen / A. John // Heart Journal. – 2010. – Vol. 31. – P. 2369–2429.

The Registry of the German Competence Network on Atrial Fibrillation: patient characteristics and initial management / M. Nabauer, A. Gerth, T. Limbourg [et al.] // Europace. – 2009. – Vol. 11. – P. 423–434.

Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation / R. Nieuwlaat, A. Capucci, A. J. Camm [et al.] // Eur. Heart J. – 2005. – Vol. 26. – P. 2422–2434.

Zoni-Berisso M. Epidemiology of atrial fibrillation: European perspective / M. Zoni-Berisso, F. Lercari // Clinical Epidemiology. – 2014. – № 6. – Vol. 213–220.

Published

2017-02-09

How to Cite

Shved, M. I., Sydorenko, O. L., Kovbasa, N. M., Beniv, M. Y., & Tsuhlevych, L. V. (2017). ANTITHROMBOTIC THERAPY AND RISK BLEEDING IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION ON THE BACKGROUND TO COMORBID DISEASES. Bulletin of Scientific Research, (4). https://doi.org/10.11603/2415-8798.2016.4.7134

Issue

Section

INTERNAL MEDICINE